Publications
243
Citations
5,079
Est. group size
~35
Recurring co-author estimate
Active years
21
Publishing since 2006
Deedra Nicolet's research focuses on blood cancers, particularly acute myeloid leukemia (AML) and related myeloid neoplasms (disorders where the body produces abnormal blood-forming cells). Recent work involves identifying genetic changes that activate cancer-related genes, developing gene-based markers to predict patient risk, and using multiple data types together to improve how these diseases are classified. This research is largely collaborative, involving large study teams and contributing supplementary data and analyses to major publications in the field.
Publication output was fairly steady at 10-14 papers per year from 2017-2022, then increased sharply from 2023 onward, reaching over 30 in recent years.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Inflammatory immune modulators of AML lung infiltration and respiratory failure
Nature Immunology · 2026
- Supplemental figure S7 from Multimodal and Data-Driven Assessment of Myeloid Neoplasms Refines Classification across Disease States
2026
- Supplemental table S2 from Multimodal and Data-Driven Assessment of Myeloid Neoplasms Refines Classification across Disease States
2026
- Supplemental figure S4 from Multimodal and Data-Driven Assessment of Myeloid Neoplasms Refines Classification across Disease States
2026
- Supplemental figure S4 from Multimodal and Data-Driven Assessment of Myeloid Neoplasms Refines Classification across Disease States
2026
- Supplemental figure S6 from Multimodal and Data-Driven Assessment of Myeloid Neoplasms Refines Classification across Disease States
2026
- Supplemental figure S9 from Multimodal and Data-Driven Assessment of Myeloid Neoplasms Refines Classification across Disease States
2026
- Supplemental figure S5 from Multimodal and Data-Driven Assessment of Myeloid Neoplasms Refines Classification across Disease States
2026
- Supplemental table S1 from Multimodal and Data-Driven Assessment of Myeloid Neoplasms Refines Classification across Disease States
2026
- Supplemental table S2 from Multimodal and Data-Driven Assessment of Myeloid Neoplasms Refines Classification across Disease States
2026
- Supplemental figure S7 from Multimodal and Data-Driven Assessment of Myeloid Neoplasms Refines Classification across Disease States
2026
- Supplemental figure S3 from Multimodal and Data-Driven Assessment of Myeloid Neoplasms Refines Classification across Disease States
2026
- Supplemental figure S8 from Multimodal and Data-Driven Assessment of Myeloid Neoplasms Refines Classification across Disease States
2026
- Supplemental figure S8 from Multimodal and Data-Driven Assessment of Myeloid Neoplasms Refines Classification across Disease States
2026
- Supplemental figure S6 from Multimodal and Data-Driven Assessment of Myeloid Neoplasms Refines Classification across Disease States
2026
- Blood×70
- Leukemia×17
- Blood Advances×7
- Haematologica×4
- Cancer Research×4
- Uma Borate
Medicine · The Ohio State University
- Ann‐Kathrin Eisfeld
Medicine · The Ohio State University
- Krzysztof Mrózek
Medicine · The Ohio State University
- Alice S. Mims
Medicine · The Ohio State University
- Bhavana Bhatnagar
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile